NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

In all likelihood, LP had been told by MHRA a while ago that no decision will be taken until the new trial policies are finalized, which is not expected until April 28 at the earliest. LP has chosen to hide this material info from shareholders. The question is will it be a rejection, conditional approval, or full approval at that point. My bet is conditional approval. Rejection is unlikely given the hiring in the last couple of months. Full approval is also less likely given no progress in reimbursement evidence submission and applications to other jurisdictions.